343 related articles for article (PubMed ID: 30268461)
1. Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study.
Stone E; Rankin N; Kerr S; Fong K; Currow DC; Phillips J; Connon T; Zhang L; Shaw T
Lung Cancer; 2018 Oct; 124():199-204. PubMed ID: 30268461
[TBL] [Abstract][Full Text] [Related]
2. Do multidisciplinary team meetings make a difference in the management of lung cancer?
Boxer MM; Vinod SK; Shafiq J; Duggan KJ
Cancer; 2011 Nov; 117(22):5112-20. PubMed ID: 21523766
[TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer.
Hung HY; Tseng YH; Chao HS; Chiu CH; Hsu WH; Hsu HS; Wu YC; Chou TY; Chen CK; Lan KL; Chen YW; Wu YH; Chen YM
PLoS One; 2020; 15(10):e0236503. PubMed ID: 33031375
[TBL] [Abstract][Full Text] [Related]
4. Effects of multidisciplinary team care on the survival of patients with different stages of non-small cell lung cancer: a national cohort study.
Pan CC; Kung PT; Wang YH; Chang YC; Wang ST; Tsai WC
PLoS One; 2015; 10(5):e0126547. PubMed ID: 25966317
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer recurrence and mortality outcomes over a 10-year period using a multidisciplinary team approach.
Nemesure B; Albano D; Bilfinger T
Cancer Epidemiol; 2020 Oct; 68():101804. PubMed ID: 32896806
[TBL] [Abstract][Full Text] [Related]
6. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature.
Pillay B; Wootten AC; Crowe H; Corcoran N; Tran B; Bowden P; Crowe J; Costello AJ
Cancer Treat Rev; 2016 Jan; 42():56-72. PubMed ID: 26643552
[TBL] [Abstract][Full Text] [Related]
7. Do Multidisciplinary Team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience.
Munro A; Brown M; Niblock P; Steele R; Carey F
BMC Cancer; 2015 Oct; 15():686. PubMed ID: 26463599
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer outcomes at a UK cancer unit between 1998-2001.
Free CM; Ellis M; Beggs L; Beggs D; Morgan SA; Baldwin DR
Lung Cancer; 2007 Aug; 57(2):222-8. PubMed ID: 17442450
[TBL] [Abstract][Full Text] [Related]
9. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
[TBL] [Abstract][Full Text] [Related]
10. Survival Outcomes Among Lung Cancer Patients Treated Using a Multidisciplinary Team Approach.
Bilfinger TV; Albano D; Perwaiz M; Keresztes R; Nemesure B
Clin Lung Cancer; 2018 Jul; 19(4):346-351. PubMed ID: 29506890
[TBL] [Abstract][Full Text] [Related]
11. Patterns of treatment and survival among older patients with stage III non-small cell lung cancer.
Driessen EJM; Schulkes KJG; Dingemans AC; van Loon JGM; Hamaker ME; Aarts MJ; Janssen-Heijnen MLG
Lung Cancer; 2018 Feb; 116():55-61. PubMed ID: 29413051
[TBL] [Abstract][Full Text] [Related]
12. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
Vinod SK; Chandra A; Berthelsen A; Descallar J
Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
[TBL] [Abstract][Full Text] [Related]
13. Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study.
Willén L; Berglund A; Bergström S; Bergqvist M; Öjdahl-Bodén A; Wagenius G; Lambe M
Lung Cancer; 2019 May; 131():40-46. PubMed ID: 31027696
[TBL] [Abstract][Full Text] [Related]
14. Strategies to improve the efficiency and utility of multidisciplinary team meetings in urology cancer care: a survey study.
Lamb BW; Jalil RT; Sevdalis N; Vincent C; Green JS
BMC Health Serv Res; 2014 Sep; 14():377. PubMed ID: 25196248
[TBL] [Abstract][Full Text] [Related]
15. [The impacts of the multidisciplinary team model on the length of stay and hospital expenses of patients with lung cancer].
Zou J; Xu X; Wang D; Xu J; Gu W
Zhonghua Jie He He Hu Xi Za Zhi; 2015 May; 38(5):370-4. PubMed ID: 26463490
[TBL] [Abstract][Full Text] [Related]
16. Trimodality therapy for stage IIIA non-small cell lung cancer: benchmarking multi-disciplinary team decision-making and function.
Dickhoff C; Hartemink KJ; van de Ven PM; van Reij EJ; Senan S; Paul MA; Smit EF; Dahele M
Lung Cancer; 2014 Aug; 85(2):218-23. PubMed ID: 24976333
[TBL] [Abstract][Full Text] [Related]
17. Preoperative multidisciplinary team assessment is associated with improved survival in patients with locally advanced colon cancer; a nationwide cohort study in 3157 patients.
Rosander E; Holm T; Sjövall A; Hjern F; Weibull CE; Nordenvall C
Eur J Surg Oncol; 2021 Sep; 47(9):2398-2404. PubMed ID: 34112562
[TBL] [Abstract][Full Text] [Related]
18. Changing trends in diagnosis, staging, treatment and survival in lung cancer: comparison of three consecutive cohorts in an Australian lung cancer centre.
Denton EJ; Hart D; Wainer Z; Wright G; Russell PA; Conron M
Intern Med J; 2016 Aug; 46(8):946-54. PubMed ID: 27177600
[TBL] [Abstract][Full Text] [Related]
19. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients--analysis based on the National Lung Cancer Audit.
Beckett P; Tata LJ; Hubbard RB
Lung Cancer; 2014 Mar; 83(3):396-400. PubMed ID: 24457105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
